ResearcherBinzhou Medical UniversityNo recent work listed

Haifeng Yu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4406-3658; OpenAlex author ID A5060208750. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2018: 1 paper

Papers 1

Stage III should be subclassified into Stage IIIA and IIIB in the American Joint Committee on Cancer (8th Edition) staging system for pancreatic cancer. Co-author DOI 10.3748/wjg.v24.i22.2400 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Xiaojun Zhang · 1 shared paper, 2018 · strength 0.09
- Paper Stage III should be subclassified into Stage IIIA and IIIB in the American Joint Committee on Cancer (8th Edition) stag… DOI 10.3748/wjg.v24.i22.2400 ↗
Wei Jiang · 1 shared paper, 2018 · strength 0.09
- Paper Stage III should be subclassified into Stage IIIA and IIIB in the American Joint Committee on Cancer (8th Edition) stag… DOI 10.3748/wjg.v24.i22.2400 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.